Van Linthout News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Van linthout. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Van Linthout Today - Breaking & Trending Today

Cardiovascular risk in systemic autoimmune diseases

In a large population-based observational study, Nathalie Conrad and colleagues1 showed
the association between 19 autoimmune diseases and 12 cardiovascular diseases (CVDs)
with data from about 22 000 000 people in the UK. However, we are concerned about
the possibly confusing message caused by treating several CVDs as a composite outcome
in this study. ....

Van Linthout , Intern Med , Rheum Dis ,

COVID-19's Relation to Myocarditis


Coronaviruses are a strand of viral illnesses that produce respiratory disease. The strand behind COVID-19, which produced a pandemic drawing international attention, differs from the other coronavirus strands. COVID-19 produces acute and severe respiratory syndromes.
1 There has been a strong link to patients developing myocarditis following COVD-19 diagnosis. The coronavirus SARS-CoV-2 causes acute and severe respiratory distress in the infected host. The virus attacks angiotensin-converting enzyme II receptors, leading to COVID-connected pneumonia. Insult to the nervous system can result in acute myocardial injury that permanently impairs the cardiovascular system.

The muscular structure of the heart can become inflamed in a condition known as ....

United States , Cooper Jr , Van Linthout , American Heart Association , Circulation Research , Reviews Cardiology , Bayl Univ Med Cent , Emergency Medical Services , Co Vid , ஒன்றுபட்டது மாநிலங்களில் , கூப்பர் ஜூனியர் , அமெரிக்கன் இதயம் சங்கம் , சுழற்சி ஆராய்ச்சி , மதிப்புரைகள் இருதயவியல் , அவசரம் மருத்துவ சேவைகள் , இணை வித் ,

Frontiers | Perinatal Cells: A Promising COVID-19 Therapy? | Bioengineering and Biotechnology


2Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy
3Pluristem Ltd., Haifa, Israel
4Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, Rome, Italy
The COVID-19 pandemic has become a priority in the health systems of all nations worldwide. In fact, there are currently no specific drugs or preventive treatments such as vaccines. The numerous therapies available today aim to counteract the symptoms caused by the viral infection that in some subjects can evolve causing acute respiratory distress syndromes (ARDS) with consequent admission to intensive care unit. The exacerbated response of the immune system, through cytokine storm, causes extensive damage to the lung tissue, with the formation of edema, fibrotic tissues and susceptibility to opportunistic infections. The inflammatory picture is also aggravated by disseminated intravascular coagulation which worsens the damage not only to the respiratory system, but also ....

South Korea , United States , United Kingdom , Cholla Bukto , Shi Yun , Kyonggi Do , Emilia Romagna , Al Khaldi , Le Blanc , Fondazione Poliambulanza Istituto Ospedaliero , Fayyad Kazan , Hamidian Jahromi , Al Jumah , Bonassi Signoroni , Mscs Nemeth , Van Linthout , Pluristem Ltd , Italian Ministry Of Research , Antiviral Properties , International Consensus Singer , Hospital Of China Medical University , Severe Acute Respiratory Syndrome Coronavirus , Precious Cell , Clinical Trials , Siping Hospital , China Medical University ,